Niresh Berinpanathan

Niresh Berinpanathan serves as a Principal at Nextech Invest, a specialized venture capital firm focused on advancing technology and life sciences investments. Operating within the firm's core investment team, he evaluates emerging biotechnology opportunities and provides dedicated strategic advisory services to oncology companies. Before entering the venture capital industry, he completed his academic training at the Swiss Federal Institute of Technology, widely known as ETH Zürich. He earned both a Master of Science and a Bachelor of Science in Biotechnology from the institution, establishing a technical foundation for analyzing complex medical therapeutics and early-stage drug pipelines. Berinpanathan now leverages this specialized scientific background to guide institutional investment strategies and support the clinical development of novel cancer treatments. His primary focus remains on bridging academic biotechnology research and commercial oncology applications to scale promising life sciences enterprises.